Type IX Osteogenesis Imperfecta

Also Known As:

Osteogenesis Imperfecta, Type IX; OI, Type IX; OI, type 9 Osteogenesis Imperfecta, type 9; OI, type IX Osteogenesis Imperfecta, type IX; OI9 Osteogenesis Imperfecta 9; Osteogenesis Imperfecta, Sillence Type II-III, Without Abnormality of Type I Collagen

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Musculoskeletal Diseases: 719
- Bone Diseases: 5863
  - Developmental Bone Diseases: 153
    - Osteochondrodysplasias: 592
      - Osteogenesis Imperfecta: 2193
        Type IX Osteogenesis Imperfecta: 1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Osteogenesis Imperfecta: 2193
    - Type IX Osteogenesis Imperfecta: 1
Skin and Connective Tissue Diseases
- Connective Tissue Diseases: 3269
  - Collagen Diseases: 754
    - Osteogenesis Imperfecta: 2193
      - Type IX Osteogenesis Imperfecta: 1

Experts

1.	Cabral, Wayne A: 1 article (01/2017)
2.	Hattori, Shunji: 1 article (01/2017)
3.	Marini, Joan C: 1 article (01/2017)
4.	Nagasawa, Masako: 1 article (01/2017)
5.	Sumida, Noriko: 1 article (01/2017)
6.	Taga, Yuki: 1 article (01/2017)
7.	Terajima, Masahiko: 1 article (01/2017)
8.	Yamauchi, Mitsuo: 1 article (01/2017)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Type IX Osteogenesis Imperfecta:

1.	Collagen Type I (Type I Collagen)IBA 01/01/2017 - "In this study, we characterized dentin type I collagen in CypB null (KO) mice, a model of recessive osteogenesis imperfecta type IX, and compared to those of wild-type (WT) and heterozygous (Het) mice. "